aluminum sulfate has been researched along with naloxone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hossieni, W; Jalili, A; Motaharinia, Y; Rahmani, MR; Rashidi, A; Rezaee, MA; Rezaie, MJ; Shapouri, R | 1 |
| Faezi, S; Mahdavi, M; Memarnejadian, A; Reza Aghasadeghi, M; Shahosseini, Z; Velashjerdi Farahani, S | 1 |
| Afshar, Z; Aleyasin, N; Banadkoki, AZ; Behrouz, B; Fatemi, MJ; Hashemi, FB; Keshavarzmehr, M | 1 |
| Azizi, H; Bagheri, A; Bazi, A; Elikaee, S; Khamesipour, A; Khatami, M; Mirzaeei, H; Mirzapour, A; Yaghoobi, H | 1 |
| Abdollahpour-Alitappeh, M; Fathi, M; Khoramabadi, N; Mahdavi, M; Nezamzadeh, R; Yazdi, MH | 1 |
| Asgarhalvaei, F; Esfandiari, B; Golkaran, B; Haghighat, S; Mahdavi, M; Mirzaee, M; Mirzaee, R; Savoji, MA; Taghizadeh, M | 1 |
6 other study(ies) available for aluminum sulfate and naloxone
| Article | Year |
|---|---|
Induction of protective immunity against brucellosis in mice by vaccination with a combination of naloxone, alum, and heat-killed Brucella melitensis 16 M.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Bacterial; Bacterial Load; Brucella melitensis; Brucella Vaccine; Brucellosis; Disease Models, Animal; Immunoglobulin G; Interferon-gamma; Interleukin-4; Male; Mice; Mice, Inbred BALB C; Naloxone; Serum; Survival Analysis; Vaccination; Vaccines, Inactivated | 2013 |
Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses.
Topics: Adjuvants, Immunologic; AIDS Vaccines; Alum Compounds; Animals; Cell Proliferation; Cytokines; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Immunity, Humoral; Immunoglobulin G; Immunoglobulin M; Mice; Mice, Inbred BALB C; Naloxone; nef Gene Products, Human Immunodeficiency Virus; Recombinant Fusion Proteins | 2016 |
Protective effect of pilin protein with alum+naloxone adjuvant against acute pulmonary Pseudomonas aeruginosa infection.
Topics: Acute Disease; Adjuvants, Immunologic; Alum Compounds; Animals; Female; Fimbriae Proteins; Humans; Mice; Mice, Inbred BALB C; Naloxone; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas Vaccines | 2016 |
A Survey on the Adjuvant Role of Naloxone Alone or Combined with Alum in Vaccination Against Fasciolosis in BALB/c Mice.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antigens, Helminth; Cell Proliferation; Cytokines; Fasciola hepatica; Fascioliasis; Female; Immunity, Cellular; Immunoglobulin G; Mice; Mice, Inbred BALB C; Naloxone; Vaccination | 2019 |
Formulation of a recombinant HIV-1 polytope candidate vaccine with naloxone/alum mixture: induction of multi-cytokine responses with a higher regulatory mechanism.
Topics: Adjuvants, Immunologic; AIDS Vaccines; Alum Compounds; Animals; Antibodies, Viral; Drug Compounding; Female; HIV Infections; HIV-1; Humans; Immunization; Interferon-gamma; Interleukins; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Naloxone | 2021 |
Montanide ISA-720 and Naloxone in HBsAg Vaccine Formulation: Cytokine Profiling and Monitoring of Long-Lasting Humoral Immune Responses.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Cytokines; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Immunity, Humoral; Immunoglobulin G; Interleukin-2; Interleukin-4; Mice; Mice, Inbred BALB C; Mineral Oil; Naloxone; Tumor Necrosis Factor-alpha | 2022 |